One possible reason is that some people on drugs such as Ozempic and Wegovy report bad breath, burping or nausea, even though halitosis is not listed as an official side effect
They address pigmentation from within, ensuring long-lasting results, especially for stubborn areas like underarms
Commenting on future research, Gasoyan told MNT that future studies should examine the comparative effectiveness of treatments for obesity in patients who discontinue their novel GLP-1 RA or dual receptor agonist medication. We are already working on the next study, where we examine the comparative effectiveness of alternative treatment options for obesity in patients who discontinue semaglutide or tirzepatide, to help patients and their clinicians make informed decisions
There are a number of name brand versions of Semaglutide on the market, including Wegovy, Ozempic, and Rybelsus
Important Safety Information Do not use AOD-9604 if you: Have a known allergy to growth hormone fragments or any component of the formulation Have been diagnosed with active cancer or have a history of malignancy (use only under medical supervision) Are pregnant or breastfeeding (safety data is lacking) Have severe uncontrolled diabetes or metabolic disorders without medical supervision Common side effects may include: Injection site reactions, mild headaches, temporary fatigue, or slight dizziness during initial use
The distinction matters because true allergies require stopping the peptide while localized histamine responses can be managed